Creative Planning’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,624
Closed -$98K 4027
2017
Q2
$98K Buy
2,624
+977
+59% +$35.3K ﹤0.01% 2015
2017
Q1
$65K Buy
1,647
+347
+27% +$13K ﹤0.01% 2281
2016
Q4
$45K Sell
1,300
-24
-2% -$942 ﹤0.01% 2483
2016
Q3
$52K Buy
1,324
+314
+31% +$12.5K ﹤0.01% 2331
2016
Q2
$38K Sell
1,010
-442
-30% -$14.8K ﹤0.01% 2340
2016
Q1
$56K Buy
1,452
+91
+7% +$3.39K ﹤0.01% 2021
2015
Q4
$65K Buy
1,361
+19
+1% +$879 ﹤0.01% 1909
2015
Q3
$53K Buy
+1,342
New +$57K ﹤0.01% 2009
2015
Q2
Sell
-1,200
Closed -$47K 3317
2015
Q1
$47K Buy
1,200
+1,000
+500% +$36.9K ﹤0.01% 2074
2014
Q4
$7K Hold
200
﹤0.01% 3348
2014
Q3
$6K Buy
+200
New +$5.52K ﹤0.01% 3227

Other funds holding NTUS

Creative Planning's NTUS Position: Q3 2017 in Review

Creative Planning sold out of Natus Medical Inc (NTUS) in Q3 2017, closing a stake of 2,624 shares — an estimated $98K sold.

Creative Planning first reported a position in NTUS in Q3 2014 and held it in 11 quarters. The position peaked at $98K in Q2 2017. 198 funds tracked by Wall St. Rank hold NTUS as of Q3 2017.

  • Creative Planning reported no remaining Natus Medical Inc position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 2,624 Natus Medical Inc shares in Q3 2017, an estimated $98K.
  • Creative Planning first reported a position in Natus Medical Inc in Q3 2014 and held it in 11 quarters.
  • Creative Planning's Natus Medical Inc position peaked at $98K in Q2 2017.
  • 198 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.